Beauty Health Company (NASDAQ: SKIN)’s stock price has decreased by -1.44 compared to its previous closing price of 1.04. However, the company has seen a -30.41% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-04-07 that PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company’s long-term investors.
Is It Worth Investing in Beauty Health Company (NASDAQ: SKIN) Right Now?
SKIN has 36-month beta value of 0.94. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for SKIN is 73.27M, and currently, short sellers hold a 11.71% ratio of that float. The average trading volume of SKIN on April 09, 2025 was 607.46K shares.
SKIN’s Market Performance
SKIN stock saw a decrease of -30.41% in the past week, with a monthly decline of -24.26% and a quarterly a decrease of -45.79%. The volatility ratio for the week is 15.49%, and the volatility levels for the last 30 days are 10.45% for Beauty Health Company (SKIN). The simple moving average for the last 20 days is -19.97% for SKIN stock, with a simple moving average of -34.51% for the last 200 days.
Analysts’ Opinion of SKIN
Many brokerage firms have already submitted their reports for SKIN stocks, with Jefferies repeating the rating for SKIN by listing it as a “Hold.” The predicted price for SKIN in the upcoming period, according to Jefferies is $1.50 based on the research report published on November 15, 2023 of the previous year 2023.
SKIN Trading at -27.85% from the 50-Day Moving Average
After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.72% of loss for the given period.
Volatility was left at 10.45%, however, over the last 30 days, the volatility rate increased by 15.49%, as shares sank -27.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.32% lower at present.
During the last 5 trading sessions, SKIN fell by -30.41%, which changed the moving average for the period of 200-days by -42.46% in comparison to the 20-day moving average, which settled at $1.2867. In addition, Beauty Health Company saw -35.22% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SKIN starting from Gruber Desiree, who sale 14,663 shares at the price of $1.50 back on Nov 20 ’24. After this action, Gruber Desiree now owns 119,514 shares of Beauty Health Company, valued at $22,022 using the latest closing price.
SAUNDERS BRENT L, the Chairman of Beauty Health Company, purchase 40,450 shares at $1.08 during a trade that took place back on Aug 12 ’24, which means that SAUNDERS BRENT L is holding 5,921,769 shares at $43,686 based on the most recent closing price.
Stock Fundamentals for SKIN
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.55 for the gross margin
The net margin for Beauty Health Company stands at -0.09. The total capital return value is set at -0.11. Equity return is now at value -52.34, with -3.60 for asset returns.
Based on Beauty Health Company (SKIN), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at 10.97. The interest coverage ratio of the stock is -6.51.
Currently, EBITDA for the company is 14.54 million with net debt to EBITDA at 19.73. When we switch over and look at the enterprise to sales, we see a ratio of 0.97. The receivables turnover for the company is 12.11for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.00.
Conclusion
To put it simply, Beauty Health Company (SKIN) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
